https://www.selleckchem.com/products/au-15330.html
The polygenic risk score model, which was based on SNPs associated with ADHD etiology at a threshold of p ≤ 0.0001 in a recent Han Chinese GWAS, predicted symptomatic improvement with ADHD medication (p = 0.018, R2 = 0.023). Conclusion Our results provide new evidence for a small influence of neurodevelopmental genes on the efficacy of medications for ADHD.Aim Eltrombopag and romiplostim are US FDA approved for treatment of immune thrombocytopenia in patients with insufficient response to other treatments. Clinical or real-world data c
Like
Comment
Share
